Armata Pharmaceuticals (ARMP) Other Operating Expenses (2014 - 2026)

Armata Pharmaceuticals (ARMP) has 8 years of Other Operating Expenses data on file, last reported at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 8.05% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2026 stood at -$2.2 million (up 71.38% YoY), and the FY2025 full-year result was -$2.1 million, up 74.54% from the prior year.
• Other Operating Expenses declined to -$2.0 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $3.2 million in Q4 2025 to a low of -$2.2 million in Q1 2024.
• A 3-year average of -$1.4 million and a median of -$2.0 million in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 245.43% in 2025 and dropped 8.05% in 2026, its largest moves.
• Tracing ARMP's Other Operating Expenses over 3 years: stood at -$2.2 million in 2024, then soared by 245.43% to $3.2 million in 2025, then sank by 163.52% to -$2.0 million in 2026.
• Business Quant data shows ARMP's Other Operating Expenses at -$2.0 million in Q1 2026, $3.2 million in Q4 2025, and -$2.0 million in Q3 2025.